Pharmacoeconomic evaluation of voriconazole vs. liposomal amphotericin B in empiric treatment of invasive fungal infections in Turkey

Turner S. J. , ŞENOL E. , KARA A., Al-Badriyeh D., DİNLEYİCİ E. Ç. , Kong D. C. M.

BMC INFECTIOUS DISEASES, cilt.13, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Background: Invasive fungal infections (IFI) are associated with considerable expense and mortality on healthcare systems. There is a need to provide evidence of both clinical efficacy and value for money with any health technology. The current pharmacoeconomic evaluation investigated the use of liposomal amphotericin B (LAmB) and voriconazole for the empiric treatment of IFI in the Turkish setting.